e-learning
resources
Vienna 2003
Sunday 28.09.2003
Burden of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I
A. Williams, S. Kay (Greenford, Macclesfield, United Kingdom)
Source:
Annual Congress 2003 - Burden of asthma
Session:
Burden of asthma
Session type:
Oral Presentation
Number:
235
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Williams, S. Kay (Greenford, Macclesfield, United Kingdom). Impact and economic burden observed in asthma patients considered as mild: an analysis of the respiratory disease specific programme I. Eur Respir J 2003; 22: Suppl. 45, 235
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008
The economic burden of respiratory diseases: COPD and asthma
Source: Eur Respir Monogr 2014; 65: 116-124
Year: 2014
Repeated hospitalizations in patients and chronic respiratory failure due to COPD are best predicted by health status (QoL) and effort tolerance
Source: Eur Respir J 2003; 22: Suppl. 45, 575s
Year: 2003
Development of a disease specific health status measure for patients with chronic cough
Source: Eur Respir J 2002; 20: Suppl. 38, 449s
Year: 2002
Chronic respiratory symptoms but normal lung function: substantial disease burden but little evidence to inform practice
Source: Eur Respir J, 54 (3) 1901363; 10.1183/13993003.01363-2019
Year: 2019
Evaluation of health related quality of life in patients with stable chronic respiratory failure
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004
Frailty in chronic respiratory disease: prevalence and comparison of rehabilitation clinical outcomes
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
Loneliness and lack of social support severely influences patients’ quality of life. Secondary findings from our focusgroup study in asthma and COPD patients
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016
Prevalence and impact of chronic respiratory disease in moderate to severe COVID-19 outcomes
Source: Virtual Congress 2021 – Clinical features and challenges of COVID-19
Year: 2021
Impact on patients' health status following early identification of a COPD exacerbation
Source: Eur Respir J 2007; 30: 907-913
Year: 2007
Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Impact of stable state symptoms on the future burden of COPD exacerbations
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Incidence and burden of major comorbidities among individuals with COPD: a comprehensive analysis using data from primary care
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Interpreting thresholds for a clinically significant change in health status in asthma and COPD
Source: Eur Respir J 2002; 19: 398-404
Year: 2002
Socioeconomic outcome of subjects experiencing asthma symptoms at work
Source: Eur Respir J 2002; 19: 1107-1113
Year: 2002
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Health status and psychological assessments
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
The effect of individual and group education on disease symptoms, pulmonary functions and quality of life in asthma patient
Source: Eur Respir J 2002; 20: Suppl. 38, 454s
Year: 2002
Detection of acute health status deterioration among COPD patients by monitoring COPD assessment test score
Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases
Year: 2011
Impact of preventing exacerbations on deterioration of health status in COPD
Source: Eur Respir J 2004; 23: 698-702
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept